Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

C Stettler, S Wandel, S Allemann, A Kastrati… - The Lancet, 2007 - thelancet.com
Background Whether the two drug-eluting stents approved by the US Food and Drug
Administration—a sirolimus-eluting stent and a paclitaxel-eluting stent—are associated with …

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of …

…, L Bott-Flügel, R Byrne, J Dirschinger, A Kastrati… - Journal of the American …, 2008 - jacc.org
Objectives : The aim of this study was to test whether the left ventricular assist device (LVAD)
Impella LP2.5 (Abiomed Europe GmbH, Aachen, Germany) provides superior …

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

RA Byrne, M Joner, A Kastrati - European heart journal, 2015 - academic.oup.com
Modern-day stenting procedures leverage advances in pharmacotherapy and device
innovation. Patients treated with contemporary antiplatelet agents, peri-procedural antithrombin …

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of …

…, S Halvorsen, G Hindricks, A Kastrati… - European heart …, 2018 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with
what is recommended in the guidelines, thus completing the loop between clinical research, …

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST …

…, S Halvorsen, K Huber, P Juni, A Kastrati… - European heart …, 2012 - academic.oup.com
The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …

…, R Hambrecht, J Herrmann, A Kastrati… - European heart …, 2011 - academic.oup.com
ESC Guidelines 3002 recommendations. To implement the guidelines, condensed pocket
guidelines versions, summary slides, booklets with essential messages, and an electronic …

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation …

…, G Filippatos, K Fox, K Huber, A Kastrati… - European heart …, 2008 - academic.oup.com
Management of acute myocardial infarction in patients presenting with persistent ST-segment
elevation | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy …

…, F Costa, A Jeppsson, P Jüni, A Kastrati… - European heart …, 2018 - academic.oup.com
OP-EHEA170455_online 213..260 Page 1 2017 ESC focused update on dual antiplatelet
therapy in coronary artery disease developed in collaboration with EACTS The Task Force for …

2018 ESC/EACTS Guidelines on myocardial revascularization

…, V Falk, SJ Head, P Jüni, A Kastrati… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS websites.
The National Societies of the ESC are encouraged to endorse, translate, and implement …

[HTML][HTML] A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

A Schömig, FJ Neumann, A Kastrati… - … England Journal of …, 1996 - Mass Medical Soc
Background The clinical benefit of coronary-artery stenting performed in conjunction with
coronary angioplasty is limited by the risk of thrombotic occlusion of the stent as well as …